Problem Drinking
Coupet E, Vaca F. Problem Drinking. 2021, 129-138. DOI: 10.1007/978-3-030-67123-5_9.ChaptersUnhealthy alcohol useAlcohol use disorderAlcohol useEmergency departmentRelated harmsTreatment service utilizationAlcohol-related injuriesAlcohol-attributable cancersGlobal disease burdenSpectrum of severityExcessive alcohol consumptionAcute conditionsUnintentional injuriesChronic conditionsDisease burdenMental Disorders Fifth EditionCancer preventionService utilizationGastrointestinal tractAlcohol abuseUse disordersAlcohol consumptionBrief interventionSBIRTStatistical ManualThe design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation
D'Onofrio G, Hawk KF, Herring AA, Perrone J, Cowan E, McCormack RP, Dziura J, Taylor RA, Coupet E, Edelman EJ, Pantalon MV, Owens PH, Martel SH, O'Connor PG, Van Veldhuisen P, DeVogel N, Huntley K, Murphy SM, Lofwall MR, Walsh SL, Fiellin DA. The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation. Contemporary Clinical Trials 2021, 104: 106359. PMID: 33737199, PMCID: PMC9153252, DOI: 10.1016/j.cct.2021.106359.Peer-Reviewed Original ResearchConceptsOpioid use disorderRandomized clinical trialsPrimary outcomeFormal addiction treatmentOpioid withdrawalClinical trialsAncillary studiesUse disordersSelf-reported opioid useAddiction treatmentEmergency department initiationIncremental cost-effectiveness ratioReceipt of medicationEmergency department studyHealth service utilizationCost-effectiveness ratioOpioid useSecondary outcomesService utilizationTreatment accessEligibility criteriaImplementation facilitationBuprenorphineOverdose eventsDepartment study